Association of metabolic risk factor clustering and all-cause mortality in adults with non-metabolic syndrome: the rural Chinese cohort study
- 15 Downloads
Studies demonstrated an increased risk of death with aggregation of metabolic syndrome (MetS) components in the general population; however, the association is unclear in people with non-MetS. We aimed to explore the effect of aggregated metabolic risk factors on all-cause mortality in the non-MetS population. Questionnaire interviews and physical and blood biochemical factors for 13,749 adult participants were analyzed at baseline between July–August 2007 and July–August 2008. We followed up 11,604 participants (84.4%) between July–August 2013 and July–October 2014. Cox proportional-hazards regression produced multivariate adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) to evaluate metabolic risk factor clustering at baseline for all-cause mortality at follow-up. During a mean of 5.93 years of follow-up, 742 deaths (508 males) occurred. With aggregated metabolic risk factors, mortality rate increased overall for male and female participants (p < 0.001). For all participants, adjusted HRs for death increased from 1.29 to 1.91 with increased number of metabolic risk factors; risk of death was increased with elevated blood pressure (BP), low high-density lipoprotein cholesterol (HDL-C) level, and high glucose level (HR 1.43 [95% CI 1.23–1.67], 1.17 [1.01–1.37], and 1.24 [1.06–1.45], respectively). A similar association was observed in males but not females, except for elevated BP. Mortality risk increases with aggregated metabolic risk factors except for females, and might be attributed to high BP, low HDL-C levels, and high glucose levels in the non-MetS Chinese population.
KeywordsCohort study Metabolic risk factor Metabolic syndrome Mortality
The authors thank all the participants of the survey and all the survey staff.
This study was supported by the National Natural Science Foundation of China (no. 81673260) and the Science and Technology Development Foundation of Shenzhen (nos. JCYJ2016030715570 and JCY20170412110537191).
Compliance with ethical standards
Conflict of interest
The authors declare that there is no conflict of interest.
- 4.Sundstrom J, Riserus U, Byberg L, Zethelius B, Lithell H, Lind L. Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study. BMJ (Clinical research ed). 2006;332(7546):878–82. https://doi.org/10.1136/bmj.38766.624097.1F. CrossRefGoogle Scholar
- 6.Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004;110(10):1245–50. https://doi.org/10.1161/01.cir.0000140677.20606.0e.
- 7.Liu L, Miura K, Fujiyoshi A, Kadota A, Miyagawa N, Nakamura Y, et al. Impact of metabolic syndrome on the risk of cardiovascular disease mortality in the United States and in Japan. Am J Cardiol. 2014;113(1):84–9. https://doi.org/10.1016/j.amjcard.2013.08.042.
- 8.Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288(21):2709–16. https://doi.org/10.1001/jama.288.21.2709.
- 9.Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007;49(4):403–14. https://doi.org/10.1016/j.jacc.2006.09.032.
- 10.Ghaem Maralani H, Tai BC, Wong TY, Tai ES, Li J, Wang JJ, et al. Metabolic syndrome and mortality in the elderly: a time-dependent association. Diabetes Res Clin Pract. 2013;99(2):209–16. https://doi.org/10.1016/j.diabres.2012.11.005.
- 12.Akbaraly TN, Kivimaki M, Ancelin ML, Barberger-Gateau P, Mura T, Tzourio C, et al. Metabolic syndrome, its components, and mortality in the elderly. J Clin Endocrinol Metab. 2010;95(11):E327–32. https://doi.org/10.1210/jc.2010-0153.
- 13.Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56(14):1113–32. https://doi.org/10.1016/j.jacc.2010.05.034.
- 15.Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Archives of InternalMedicine. 2004;164(10):1066–76. https://doi.org/10.1001/archinte.164.10.1066.CrossRefGoogle Scholar
- 16.Kadota A, Hozawa A, Okamura T, Kadowak T, Nakmaura K, Murakami Y, et al. Relationship between metabolic risk factor clustering and cardiovascular mortality stratified by high blood glucose and obesity: NIPPON DATA90, 1990-2000. Diabetes Care. 2007;30(6):1533–8. https://doi.org/10.2337/dc06-2074.
- 17.Franks PW, Olsson T. Metabolic syndrome and early death: getting to the heart of the problem. Hypertension. 2007;49(1):10–2. https://doi.org/10.1161/01.HYP.0000251934.55488.ae.CrossRefPubMedGoogle Scholar
- 18.Chen WW, Gao RL, Liu LS, Zhu ML, Wang W, Wang YJ, et al. Report on cardiovascular disease (2016): abstract. Chin Circul J. 2017;32(6):521–30. https://doi.org/10.3969/j.issn.1000-3614.2015.07.001.
- 21.Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24(4):683–9. https://doi.org/10.2337/diacare.24.4.683.
- 22.Hong Y, Jin X, Mo J, Lin HM, Duan Y, Pu M, et al. Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality--results of prospective analysis for the Atherosclerosis Risk in Communities study. J Intern Med. 2007;262(1):113–22. https://doi.org/10.1111/j.1365-2796.2007.01781.x.
- 23.Zambon S, Zanoni S, Romanato G, Corti MC, Noale M, Sartori L, et al. Metabolic syndrome and all-cause and cardiovascular mortality in an Italian elderly population: the Progetto Veneto Anziani (Pro.V.A.) Study. Diabetes Care. 2009;32(1):153–9. https://doi.org/10.2337/dc08-1256.CrossRefPubMedPubMedCentralGoogle Scholar